MA, M., YC, C., STS, C., RJ, A., MW, R., A, C., . . . BJ, C. (2022). 6″-Modifed α-GalCer-peptide conjugate vaccine candidates protect against liver-stage malaria. RSC chemical biology, 3(5), 551. https://doi.org/10.1039/d1cb00251a
Chicago Style (17th ed.) CitationMA, Meijlink, et al. "6″-Modifed α-GalCer-peptide Conjugate Vaccine Candidates Protect Against Liver-stage Malaria." RSC Chemical Biology 3, no. 5 (2022): 551. https://doi.org/10.1039/d1cb00251a.
MLA (9th ed.) CitationMA, Meijlink, et al. "6″-Modifed α-GalCer-peptide Conjugate Vaccine Candidates Protect Against Liver-stage Malaria." RSC Chemical Biology, vol. 3, no. 5, 2022, p. 551, https://doi.org/10.1039/d1cb00251a.
Warning: These citations may not always be 100% accurate.